Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Advik Laboratories Ltd

NSE: ADVIKLA · BSE: 531686 · Pharmaceuticals & Biotechnology · 13 announcements

Share price
₹2.08
Market cap
₹3.98 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-1.02 Cr
P/E (TTM)
-3.8×Sector 47.4×
Promoter holding
35.89%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:14 IST BSE
Other Announcement

Advik Laboratories Other Announcement

MPS Pharmaa Limited announced the availability of its FY 2025-26 Annual Report on its website. It also requested shareholders to update their KYC and PAN details.

13:42 IST BSE
Other Announcement

Advik Laboratories Other Announcement

Advik Laboratories Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing provides the distribution of shares among promoters and public shareholders.

22:48 IST BSE
Other Announcement

Advik Laboratories Other Announcement

MPS Pharmaa Limited filed its Annual Secretarial Compliance Report for the financial year ended March 2026. The report details governance compliance and historical listing fee defaults.

16:47 IST BSE
Other Announcement

Advik Laboratories Other Announcement

MPS Pharmaa Limited (formerly Advik Laboratories Limited) reported nil investor complaints for the quarter ended March 31, 2026. The company started, received, and disposed of zero complaints during the period, ending the quarter with no unresolved grievances.